Zacks Investment Research on MSN2h
BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant
Biogen BIIB announced that dosing has begun in a phase III study evaluating its key pipeline candidate, felzartamab, in adult kidney transplant recipients diagnosed with late antibody-mediated ...
Clinical Trials Arena on MSN8h
Hansa Biopharma enrols all subjects in imlifidase trial for kidney transplants
Swedish biotechnology company Hansa Biopharma has finished enrolling subjects in a Phase III trial in Europe evaluating ...